Pieris Pharmaceuticals to Present at 43rd Annual Deutsche Bank Health Care Conference
May 03, 2018 12:01 pm UTC| Business
BOSTON, May 03, 2018 -- Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform for cancer, respiratory and other...
May 03, 2018 12:01 pm UTC| Business
SAN CARLOS, Calif., May 03, 2018 -- Iovance Biotherapeutics, Inc. (NASDAQ:IOVA), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, today announced...
Depomed to Report First-Quarter 2018 Financial Results on Thursday, May 10, 2018
May 03, 2018 12:01 pm UTC| Business
LAKE FOREST, Ill., May 03, 2018 -- Depomed, Inc. (NASDAQ:DEPO) today announced that it will release first-quarter 2018 financial results on Thursday, May 10, 2018, before the open of markets. Following the announcement,...
Onconova Therapeutics to Present at the Disruptive Growth and Healthcare Conference on May 8th, 2018
May 03, 2018 12:01 pm UTC| Business
NEWTOWN, Pa., May 03, 2018 -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with a primary focus on...
May 03, 2018 12:00 pm UTC| Business
BASKING RIDGE, N.J., May 03, 2018 -- Caladrius Biosciences, Inc. (Nasdaq:CLBS) (“Caladrius” or the “Company”), a development-stage biopharmaceutical company with multiple technology platforms targeting autoimmune and...
May 03, 2018 12:00 pm UTC| Business
Key Opinion Leader Luncheon to Take Place in New York City on May 10 SANTA MONICA, Calif., May 03, 2018 -- Opiant Pharmaceuticals, Inc. ("Opiant") (NASDAQ:OPNT), a specialty pharmaceutical company developing...
May 03, 2018 12:00 pm UTC| Business
MONTREAL, May 03, 2018 -- Prevtec Microbia Inc. (“Prevtec”) is pleased to announce that five million doses of its bivalent vaccine Coliprotec® F4/F18 have been sold in the European Union (EU) since its commercial market...